Literature DB >> 29943497

Increased exhausted CD8+ T cells with programmed death-1, T-cell immunoglobulin and mucin-domain-containing-3 phenotype in patients with multiple myeloma.

Jiaxiong Tan1, Shaohua Chen1, Jingying Huang1, Youchun Chen1, Lijian Yang1, Chunli Wang1, Jun Zhong1, Yuhong Lu1, Liang Wang2, Kanger Zhu1, Yangqiu Li1,3.   

Abstract

AIM: The immunosuppressive microenvironment plays a crucial role in T-cell immunodeficiency in multiple myeloma (MM). Overexpression of T-cell immunosuppressive receptors, including programmed death-1 (PD-1) and T-cell immunoglobulin and mucin-domain-containing-3 (Tim-3), may be related to tumor immunosuppression and poor prognosis, and the malignant bone marrow (BM) microenvironment may contribute to such immunosuppression. The purpose of this study was to analyze the distribution of PD-1+ and/or Tim-3+ T cells in different T-cell subset in patients with MM.
METHODS: The expression of PD-1 and Tim-3 with exhausted (CD244+ and CD57+ ) CD3+ , CD4+ and CD8+ T cells between BM and peripheral blood (PB) from 10 patients with untreated MM was detected by multicolor flow cytometry assay.
RESULTS: A significant increase in both PD-1+ CD57+ and Tim-3+ CD57+ CD3+ T cells and PD-1+ Tim-3+ CD3+ T cells was detected in PB from patients with MM compared with 10 healthy individuals (HIs), and the alteration was mostly in the CD8+ T-cell subset. Significant higher percentage of PD-1+ CD3+ T cells was found in BM compared with PB from patients with MM. The level of PD-1+ Tim-3+ CD3+ , CD4+ , and CD8+ T cells was high in BM group compared with PB. Moreover, PD-1+ CD244+ or PD-1+ CD57+ CD3+ T cells, particularly PD-1+ CD244+ and PD-1+ CD57+ CD8+ T cells were significantly higher in BM than in PB. In addition, limited dynamic detection data from three MM cases who achieved complete remission after treatment showed that the numbers of either PD-1+ or PD-1+ Tim-3+ T cells in different T-cell subsets were decreased in both BM and PB.
CONCLUSION: We characterized the distribution of PD-1 and TIM-3 concurrent with exhausted CD3+ , CD4+ and CD8+ T cells between BM and PB from patients with MM. Higher numbers of PD-1+ CD244+ or PD-1+ CD57+ CD3+ T cells in BM from patients with MM may contribute to mediate the BM immunosuppressive microenvironment. Although heterogeneous alterations in Tim-3+ T cells may represent a complex immunosuppressive pattern in MM. Overall, higher levels of PD-1+ CD244+ or PD-1/Tim-3+ CD57+ CD8+ T cells may be a major reason for lower T-cell activation and T-cell immunodeficiency in MM.
© 2018 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  PD-1; T-cell exhaustion; T-cell subset; Tim-3; multiple myeloma

Mesh:

Substances:

Year:  2018        PMID: 29943497     DOI: 10.1111/ajco.13033

Source DB:  PubMed          Journal:  Asia Pac J Clin Oncol        ISSN: 1743-7555            Impact factor:   2.601


  8 in total

1.  Lower T cell inhibitory receptor level in mononuclear cells from cord blood compared with peripheral blood.

Authors:  Ying Lin; Jinrong Lin; Jingying Huang; Youchun Chen; Jiaxiong Tan; Yangqiu Li; Shaohua Chen
Journal:  Stem Cell Investig       Date:  2019-10-21

Review 2.  CD4 T-Cell Exhaustion: Does It Exist and What Are Its Roles in Cancer?

Authors:  Alexandra M Miggelbrink; Joshua D Jackson; Selena J Lorrey; Ethan S Srinivasan; Jessica Waibl-Polania; Daniel S Wilkinson; Peter E Fecci
Journal:  Clin Cancer Res       Date:  2021-06-14       Impact factor: 12.531

3.  Quantitative and functional characteristics of circulating and bone marrow PD-1- and TIM-3-positive T cells in treated multiple myeloma patients.

Authors:  Egor V Batorov; Tatiana A Aristova; Vera V Sergeevicheva; Svetlana A Sizikova; Galina Y Ushakova; Natalia V Pronkina; Irina V Shishkova; Ekaterina Y Shevela; Alexander A Ostanin; Elena R Chernykh
Journal:  Sci Rep       Date:  2020-11-30       Impact factor: 4.379

4.  Study on Tim3 Regulation of Multiple Myeloma Cell Proliferation via NF-κB Signal Pathways.

Authors:  Zhaoyun Liu; Chenhuan Xiang; Mei Han; Nanhao Meng; Jingyi Luo; Rong Fu
Journal:  Front Oncol       Date:  2020-11-19       Impact factor: 6.244

Review 5.  Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia.

Authors:  Alessandro Allegra; Alessandro Tonacci; Caterina Musolino; Giovanni Pioggia; Sebastiano Gangemi
Journal:  Front Immunol       Date:  2021-10-25       Impact factor: 7.561

6.  BET bromodomain inhibition rescues PD-1-mediated T-cell exhaustion in acute myeloid leukemia.

Authors:  Mengjun Zhong; Rili Gao; Ruocong Zhao; Youxue Huang; Cunte Chen; Kehan Li; Xibao Yu; Dingrui Nie; Zheng Chen; Xin Liu; Zhuandi Liu; Shaohua Chen; Yuhong Lu; Zhi Yu; Liang Wang; Peng Li; Chengwu Zeng; Yangqiu Li
Journal:  Cell Death Dis       Date:  2022-08-02       Impact factor: 9.685

Review 7.  Molecular Impact of the Tumor Microenvironment on Multiple Myeloma Dissemination and Extramedullary Disease.

Authors:  Stefan Forster; Ramin Radpour
Journal:  Front Oncol       Date:  2022-07-01       Impact factor: 5.738

8.  Increased PD-1+Tim-3+ exhausted T cells in bone marrow may influence the clinical outcome of patients with AML.

Authors:  Jiaxiong Tan; Zhi Yu; Jingying Huang; Youchun Chen; Shuxin Huang; Danlin Yao; Ling Xu; Yuhong Lu; Shaohua Chen; Yangqiu Li
Journal:  Biomark Res       Date:  2020-02-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.